Stay updated on Safety of PF-06939926 Gene Therapy in Duchenne Clinical Trial
Sign up to get notified when there's something new on the Safety of PF-06939926 Gene Therapy in Duchenne Clinical Trial page.

Latest updates to the Safety of PF-06939926 Gene Therapy in Duchenne Clinical Trial page
- ChecktodayChange DetectedRevision: v3.5.4 has been added, replacing the previous Revision: v3.5.3 on the page, indicating a new release/version of the page metadata.SummaryDifference0.0%

- Check7 days agoNo Change Detected
- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedRevision tag updated from v3.5.2 to v3.5.3. This change represents a minor page version update and does not alter trial data or the visible content.SummaryDifference0.0%

- Check29 days agoChange DetectedThe page’s revision label was updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check43 days agoChange DetectedDeleted detailed outcome measures and safety event tables from the Study Results page, including all-Cause TEAEs, SAEs by SOC/PT, and related safety summaries.SummaryDifference12%

- Check58 days agoChange DetectedAdded Revision: v3.5.0 and deleted Revision: v3.4.3, indicating a minor site version update.SummaryDifference0.0%

- Check73 days agoChange DetectedVersion updated from v3.4.2 to v3.4.3; a minor update/patch.SummaryDifference0.0%

Stay in the know with updates to Safety of PF-06939926 Gene Therapy in Duchenne Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety of PF-06939926 Gene Therapy in Duchenne Clinical Trial page.